Citigroup’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$270K 5880
2022
Q2
$270K Buy
+10,000
New +$290K ﹤0.01% 3666
2019
Q4
Sell
-1,000
Closed -$2K 7679
2019
Q3
$2K Sell
1,000
-500
-33% -$1.16K ﹤0.01% 7527
2019
Q2
$4K Buy
+1,500
New +$5.09K ﹤0.01% 7519
2018
Q3
Sell
-3,393
Closed -$26K 7752
2018
Q2
$26K Buy
3,393
+866
+34% +$11.6K ﹤0.01% 6782
2018
Q1
$88K Buy
2,527
+2,227
+742% +$86.3K ﹤0.01% 5720
2017
Q4
$13K Sell
300
-1,300
-81% -$55.7K ﹤0.01% 6914
2017
Q3
$69K Sell
1,600
-180
-10% -$6.75K ﹤0.01% 5826
2017
Q2
$66K Sell
1,780
-1,360
-43% -$60.2K ﹤0.01% 5603
2017
Q1
$170K Buy
3,140
+2,047
+187% +$107K ﹤0.01% 4788
2016
Q4
$58K Buy
1,093
+6
+0.6% +$341 ﹤0.01% 6075
2016
Q3
$66K Sell
1,087
-1,480
-58% -$92.2K ﹤0.01% 5477
2016
Q2
$169K Buy
2,567
+194
+8% +$12.3K ﹤0.01% 4643
2016
Q1
$135K Buy
2,373
+1,973
+493% +$222K ﹤0.01% 5441
2015
Q4
$94K Sell
400
-140
-26% -$30.5K ﹤0.01% 5418
2015
Q3
$85K Buy
540
+273
+102% +$77.3K ﹤0.01% 5079
2015
Q2
$101K Buy
267
+234
+709% +$92.9K ﹤0.01% 4983
2015
Q1
$14K Buy
+33
New +$11.8K ﹤0.01% 6279

Other funds holding CLDX